JENNIFER BACKUS: Open Payments
NPI 1023503760 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,547 in 73 payments from 19 companies in 2025. Trend: 2023 $171 · 2024 $2,553 · 2025 $2,547
Food & beverage: $1,747Consulting: $800
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 11 | $1,278 |
| Mannkind Corporation | 11 | $223 |
| Lilly USA, LLC | 10 | $135 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $120 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Novo Nordisk Inc | 5 | $94 |
| Corcept Therapeutics | 4 | $93 |
| Madrigal Pharmaceuticals | 2 | $75 |
| Abbott Laboratories | 4 | $69 |
| Radius Health, Inc. | 2 | $55 |
Products named: TZIELD, AFREZZA, ISTURISA, MOUNJARO, LEQVIO, Korlym, REZDIFFRA, Wegovy.
Industry payments across GA — which companies pay providers there.
